Food
and Drug Administration
Center
for Drug Evaluation and Research
Oncologic Drugs Advisory Committee Meeting
Briefing
Material:
PM
session – CRC End Points
Table of Contents:
Memo from: Richard Pazdur, M.D.
Director, Division of Oncology Drug
Products
Tab 1: Johnson,
John R., Williams, Grant & Pazdur, Richard.
(2003) Endpoints and
Tab 2: Summary of